Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Begoña Monge-Maillo

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Drugs|October 31, 2013
Therapeutic options for visceral leishmaniasisBegoña Monge-Maillo, Rogelio López-Vélez
AIDS Reviews|March 4, 2016
Treatment Options for Visceral Leishmaniasis and HIV CoinfectionBegoña Monge-Maillo, Rogelio López-Vélez
Expert Review of Anti-Infective Therapy|May 26, 2011
Is screening for malaria necessary among asymptomatic refugees and immigrants coming from endemic countries?Begoña Monge-Maillo, Rogelio López-Vélez
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2015
Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendationsBegoña Monge-Maillo, Rogelio López-Vélez
Current Opinion in Infectious Diseases|July 16, 2024
Leishmaniasis in transplant patients: what do we know so far?Begoña Monge-Maillo, Rogelio López-Vélez
Current Opinion in Infectious Diseases|August 18, 2023
Cystic echinococcosis of the boneBegoña Monge-Maillo, Rogelio Lopez-Velez
Mediterranean Journal of Hematology and Infectious Diseases|April 27, 2012
Migration and malaria in europeBegoña Monge-Maillo, Rogelio López-Vélez
Drugs|October 31, 2013
Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasisBegoña Monge-Maillo, Rogelio López-Vélez
The American Journal of Tropical Medicine and Hygiene|June 6, 2014
Topical paromomycin and gentamicin for new world cutaneous leishmaniasis in PanamaBegoña Monge-Maillo, Rogelio López-Vélez
Revista Iberoamericana De Micologia|June 15, 2021
Anfotericina B liposomal en el tratamiento de la leishmaniasis visceralBegoña Monge-Maillo, Rogelio López-Vélez
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Drugs|October 31, 2013
Therapeutic options for visceral leishmaniasisBegoña Monge-Maillo, Rogelio López-Vélez
AIDS Reviews|March 4, 2016
Treatment Options for Visceral Leishmaniasis and HIV CoinfectionBegoña Monge-Maillo, Rogelio López-Vélez
Expert Review of Anti-Infective Therapy|May 26, 2011
Is screening for malaria necessary among asymptomatic refugees and immigrants coming from endemic countries?Begoña Monge-Maillo, Rogelio López-Vélez
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2015
Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendationsBegoña Monge-Maillo, Rogelio López-Vélez
Current Opinion in Infectious Diseases|July 16, 2024
Leishmaniasis in transplant patients: what do we know so far?Begoña Monge-Maillo, Rogelio López-Vélez
Current Opinion in Infectious Diseases|August 18, 2023
Cystic echinococcosis of the boneBegoña Monge-Maillo, Rogelio Lopez-Velez
Mediterranean Journal of Hematology and Infectious Diseases|April 27, 2012
Migration and malaria in europeBegoña Monge-Maillo, Rogelio López-Vélez
Drugs|October 31, 2013
Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasisBegoña Monge-Maillo, Rogelio López-Vélez
The American Journal of Tropical Medicine and Hygiene|June 6, 2014
Topical paromomycin and gentamicin for new world cutaneous leishmaniasis in PanamaBegoña Monge-Maillo, Rogelio López-Vélez
Revista Iberoamericana De Micologia|June 15, 2021
Anfotericina B liposomal en el tratamiento de la leishmaniasis visceralBegoña Monge-Maillo, Rogelio López-Vélez
Pageof 7